ODP560 Thyroid Hormones membrane receptor, Integrin αvβ3, as a potential prognostic marker of chemotherapy response in breast cancer

Despite the development of novel therapies, breast cancer (BC) tumors are treated with conventional therapy eventually. Due to tumor heterogeneity, it is necessary to define new biomarkers to identify groups with different molecular characteristic and on this basis improve the treatment decision. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Haedo, Mateo Campos, Florencia Cayrol, M, Cremaschi, Graciela, Mercedes Debernardi, M, Albuja, Johanna Diaz, Albuja, M Celeste Díaz, Alejandra Paulazo, M, Rosemblit, Cinthia, Sterle, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627778/
http://dx.doi.org/10.1210/jendso/bvac150.1813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627778/
http://dx.doi.org/10.1210/jendso/bvac150.1813

Ejemplares similares